Supplement Review · Women’s Bladder Health · 2026
Uqora sells more than one product, and they solve different problems. This review focuses on In Control, its bladder-muscle formula — the one most relevant to occasional urgency and leaks — and explains where the rest of the Uqora lineup fits in.
Uqora is made by Bonafide Health, LLC, a New York–based women’s health company that also makes Relizen. It’s a bigger, more established operation than most single-product DTC brands in this category, and it sells several distinct products under one name — which causes real confusion in search (“does Uqora work?” means different things depending on which product someone means). We’re focusing this review on In Control, the product built for occasional bladder urgency, frequency, and leaks, since that’s what belongs in a bladder-control comparison. We explain the rest of the lineup below so you don’t buy the wrong one.
Our Overall Rating (In Control)
8.8
7.5
7.0
8.0
Quick Pros & Cons
Pros
- Uses Urox® by name — the actual branded, standardized extract tested in a real published randomized controlled trial, not a similarly-sourced blend of the same herbs
- Standardized to a minimum 3mg lupeol marker compound, a meaningfully more precise transparency signal than most competitors’ blend-total-only labels
- 60-day, no-questions-asked money-back guarantee with genuinely easy cancellation
- True one-time purchase option exists alongside the subscription
- Established company (Bonafide Health) with 800,000+ customers and a large, unfiltered public review base
Cons
- Checkout nudges you toward subscribing (“you’re 4 times more likely to succeed if you subscribe… are you sure you don’t want to subscribe?”) before letting you complete a one-time purchase
- Public reviews are genuinely mixed: 2,238 ratings average 4.0/5, but about 18% are 1–2 stars and another 11% are 3 stars — worth knowing before assuming universal success
- Brand name confusion: “Uqora” covers In Control (bladder muscle), Flush/Defend/Promote (UTI prevention), and hygiene products — easy to buy the wrong one for your symptoms
- No microbiome/probiotic component — muscle-tone mechanism only
What Is Uqora In Control?
In Control is a once-daily, two-capsule supplement built around 840mg of Urox® Proprietary Blend — horsetail (Equisetum arvense), spicebush/Lindera (Lindera aggregata), and three-leaf caper/Crataeva (Crataeva nurvala), standardized to a minimum of 3mg lupeol. The mechanism is bladder-muscle function, not microbiome balance: the goal is to support normal detrusor muscle behavior to reduce occasional urgency, frequency, and leaks associated with normal aging.
The detail that matters most here: Urox is the same standardized extract studied in a published, peer-reviewed randomized controlled trial (Schoendorfer et al., BMC Complementary Medicine and Therapies, 2018, n=150) that found significant reductions in urinary frequency, nocturia, urgency, and both urgency and stress incontinence at 8 weeks versus placebo. Because Uqora licenses and names Urox directly on the label, this is one of the few products in the category where we can say the finished product plausibly matches what was actually studied — a real distinction from products using similarly-named herbs without confirming the same standardized extract.
The Rest of the Uqora Lineup — So You Don’t Buy the Wrong One
If your issue isn’t bladder-muscle urgency, In Control isn’t the right Uqora product:
Flush / Defend / Promote — recurrent UTI prevention
Uqora’s better-known product line centers on D-Mannose (Flush), along with Defend and Promote, aimed at people prone to recurrent urinary tract infections — a completely different problem from general bladder control. D-Mannose has real published research behind it for UTI prevention specifically. If recurrent UTIs are your issue, this regimen — not In Control — is the one to research.
Wash & Wipes — hygiene, not treatment
pH-balanced cleansing products positioned as supportive hygiene, not a treatment for urgency, leaks, or infection.
Pricing & Guarantee
In Control runs $34.99 for a one-time purchase (one-month supply, 60 capsules), with subscription options offering meaningful discounts (roughly 14–26% off depending on frequency) and free shipping. The checkout defaults toward encouraging the subscription with messaging like “you’re 4 times more likely to succeed if you subscribe” before confirming a one-time order — a soft nudge, not a hidden trap, since the one-time option is clearly available and not buried.
The 60-day money-back guarantee is genuinely strong: no questions asked, and the brand explicitly states there are no penalties for cancelling a subscription.
What Real Customers Say
Uqora publishes its reviews unfiltered, which we think is worth crediting directly: 2,238 ratings for In Control average 4.0 out of 5 stars, with 71% saying they’d recommend it. Breaking that down honestly: roughly 58% are 5-star, 14% are 4-star, but a combined 18% land at 1–2 stars — and 11% more sit at 3 stars, meaning close to three in ten reviewers were lukewarm or worse. That’s a meaningfully more mixed picture than the curated testimonial carousel on the sales page suggests — a real product with real variation in results, not a universal fix.
Who Might Consider It — And Who Shouldn’t
Might consider: women whose main issue is bladder-muscle urgency and frequency specifically, who want a formula tied to real trial evidence, and who are comfortable navigating a subscription-nudging checkout to get a one-time purchase.
Should skip: anyone whose main issue is recurrent UTIs (look at Uqora’s own Flush/Defend line, or a straightforward D-Mannose product instead), anyone wanting a microbiome/probiotic angle, and anyone with new, painful, or worsening urinary symptoms — those need a doctor. As always, pelvic floor exercises have stronger clinical evidence than any supplement for stress-related leaks.
How It Stacks Up Against Our Top Pick
Compared with FemiCore — our current top pick in this category — Uqora In Control has the edge on trial-to-product fidelity: Urox is directly, confirmably the extract studied in a real RCT. FemiCore’s edge is mechanism completeness (it adds a microbiome/probiotic angle Urox doesn’t touch) and a cleaner checkout with no subscription nudge at all. Which is “better” genuinely depends on your symptom pattern rather than one product being objectively superior — see our fuller breakdown in FemiCore vs. Uqora and our 2026 bladder supplement rankings.
Want a Microbiome Angle Instead?
If your symptoms include a broader pattern beyond muscle urgency, FemiCore remains our #1 pick for 2026 — rated 8.4/10 in our full review.
Frequently Asked Questions
Is Uqora legit?
Yes — it’s made by Bonafide Health, LLC, an established women’s health company, and In Control’s core ingredient is a directly named, standardized extract with real published clinical trial support. That’s more verifiable than most competitors in this category can offer.
Does Uqora In Control actually work?
The underlying Urox extract has real trial evidence behind it (significant improvements versus placebo at 8 weeks in a 150-person RCT). Public customer reviews are genuinely mixed — a clear majority positive (about 72% at 4–5 stars), but a meaningful minority (about 18%) rate it 1–2 stars. Treat it as a reasonable, evidence-backed option, not a guaranteed fix.
Which Uqora product do I need?
In Control is for occasional bladder-muscle urgency, frequency, and leaks. Flush/Defend/Promote are for recurrent UTI prevention — a different problem entirely. Buying the wrong one for your symptom pattern is the most common mistake in this category.
Is there a subscription trap?
No hidden trap, but the checkout does actively encourage subscribing before confirming a one-time purchase. The one-time option is available and not hidden; you just have to decline the subscription prompt.
Sources & References
How we use evidence: pricing, guarantee terms, and review statistics in this article are based on Uqora’s official product page, checked in August 2026. Terms and pricing can change without notice.
- Schoendorfer et al., “Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double-blind placebo controlled trial” — BMC Complementary Medicine and Therapies, 2018, PMID 29385990.
- Uqora In Control official product page — uqora.com, last checked August 2026.
Our Verdict
Uqora In Control earns a 7.6/10 — the strongest ingredient-to-evidence match we’ve found in this category, since Urox is directly, confirmably the extract behind a real published trial. It loses ground to our top pick on checkout friction (the subscription nudge) and on mechanism completeness (no microbiome angle). If bladder-muscle urgency is specifically your pattern, and you’re comfortable navigating a soft subscription push, it’s a legitimately well-evidenced option.